Age alone should not preclude TAVI in patients aged ≥90 years

The clinical frailty score currently used to assess suitability for transcatheter aortic valve implantation (TAVI) requires further refinement, a study published in the American...

The findings on transcatheter aortic valve implantation in patients who are at low risk...

Recent low-risk trials for TAVI look set to expand its indications for use. Amar Krishnaswamy and Samir Kapadia assess the impact of the findings...

Edwards Lifesciences to discontinue its self-expanding valve Centera

Edwards Lifesciences has announced it has made the “difficult decision” to discontinue its self-expanding transcatheter aortic valve implantation (TAVI) device Centera. The company says...

Edwards Lifesciences issues urgent safety notice for Sapien 3 Ultra

Edwards Lifesciences has issued an urgent safety notice for the latest generation of its Sapien device, Sapien 3 Ultra, after it received reports of...

Adrian Banning

Robert W Yeh

Olaf Wendler

(Visited 2,915 times, 1 visits today)